PDCD1 and lung cancer: α-T-K reprogrammed M2 macrophages under hypoxia by increasing glycolysis and reducing fatty acid oxidation, leading to delayed tumor growth in the 4T1 BCa model and enhanced the efficacy of PD-1 ICI in the LLC lung cancer model.